COVID-19, SARS-CoV-2, IFR, Lethality, Age, Gender, Adjusted
lethality
1. Introduction
Since it was first identified in pneumonia patients in Wuhan, China, the coro-
navirus disease 2019 (COVID-19) by severe acute respiratory syndrome coron-
avirus 2 (SARS-CoV-2) has been characterized by its fast-spreading and high
related disease burden [1]. The spectrum of symptoms is wide and ranges from5
asymptomatic infection to severe respiratory illness [2]. By August 4, 2020, al-
most 20 million confirmed cases of COVID-19 had been reported globally and a
fatal outcome was registered in nearly a half million of them [3]. Gender and age-
related differences in disease severity and risk of death have been documented
[4].10
∗Corresponding author
Email addresses:
[email protected] (Carlos Hernandez-Suarez),
[email protected] (Efren Murillo-Zamora)
Preprint submitted to medRxive August 8, 2020
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted August 11, 2020. ; https://doi.org/10.1101/2020.06.28.20142117doi: medRxiv preprint
NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.
The lethality of a disease, also known as Infection Fatality Rate (IFR) is the
fraction of infected individuals that die from the disease. It’s estimation is of the
upmost importance for the design of and application of containment measures
and to decide if lockdowns are implemented as when these should be reinforced
or lifted. Unfortunately, our data does not come from a random sample and we15
cannot estimate the IFR, instead, we estimate the relative share of the IFR by
age group and gender and introduce the concept of adjusted lethalities that can
be used to project the burden of the disease for a population whose demographic
characteristics is known.
Methodology20
We used the database of the Instituto Mexicano de Seguro Social (IMSS,
acronym for Mexican Institute for National Insurance) with confirmed SARS-
CoV-2 cases. The IMSS provides health services to about 10% of the population
in Mexico, over 12 million persons. The database on SARS-CoV-2 we used
contains confirmed cases from January 2 to June 23, 2020. We included only25
cases with disease outcome as dead or recovered, leaving a database with 102,985
cases, from which 55 % were males and 45% females.
When a patient is diagnosed with COVID-19, it follows one of the paths
depicted in Figure 1. With this data we constructed Table 1 after dividing the
population in seven age categories and two genders.30
Table 2 shows a processing of the information in Table 1. Vectors h, c, d
and dc in Table 2 are described as follows:
h = relative frequency of hospitalized patients.
c = fraction requiring ICU among those that went into hospitalization.35
d = fraction dying among those that went into hospitalization.
dc = fraction dying among those that went into ICU.
As mentioned before, it is not possible to estimate the IFR from the data
2
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted August 11, 2020. ; https://doi.org/10.1101/2020.06.28.20142117doi: medRxiv preprint
N Hospital
Dead
Home
Health servicesICUN1N2N3
N4
N5
N6
N0
Figure 1: Transitions in our model: N0 + N1 = N, N2 + N3 + N4 = N1, N5 + N6 = N3
available (Table 1) since the death rates are conditional on patients mostly40
symptomatic and thus they are not a representative sample of the response to
an infection. Nevertheless, there is a couple of things that we can obtain from
Table 2. The fist one is the relative lethality and the second adjusted lethality.
2. Relative lethality
Table 2 tells us, for instance, that the probability that a female person in45
age group 40-49 that is hospitalized from infection with SARS-CoV-2 dies is
0.3548, but this does not provides information on the probability that a female
infected person in age group 40-49 dies from the disease. Nevertheless, observe
that if fij is the fraction in the population of individuals of gender i,i = 1, 2
and group age j,j = 1, 2,..., 7., and we assume that everyone is equally likely50
to become infected but there is a differential response to the disease, then, if
p is the fraction of individuals in the population that is infected and βij is
the fraction of infected individuals of gender i and age group j that become
hospitalized, then:
3
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted August 11, 2020. ; https://doi.org/10.1101/2020.06.28.20142117doi: medRxiv preprint
fij p βij∝hij (1)
Wherehij is the fraction of hospitalized that belong to age groupi and genderj.55
Now, if αij is the fraction of individuals hospitalized that die from COVID-19,
then
fij p βijαij∝hijdij (2)
where dij is the fraction of individuals of these hospitalized that dies.
Letθij be the lethality or infection fatality rate of gender i and age group j,
then, the lethality of gender i and age group j can be written as:60
θij =βijαij. (3)
Thus, the IFR by gender and group age follows this relationship:
θij∝hijdij/fij. (4)
The reason why we only establish that θij is proportional to some value is
because we ignore the value of p, the true proportion of infected individuals in
the population. Thus, we define θ∗
ij as the relative lethalitiy :
θ∗
ij =hijdij/fij (5)
Even although the value of p is not known, the ratio of any two relative
lethalities θ∗
ij/θ∗
kl reflects the ratio of the true lethalities, that is:
θ∗
ij/θ∗
kl =θij/θkl,
therefore this quotient can be used to compare the lethality of any two groups.65
Table 3 shows in the last column the relative infection fatality rates in (5) , after
normalization. In this table f M and f F are the relative frequencies by age group
and gender in the Mexican population. In this table we can see, for instance,
that the lethality of COVID-19 in age group 60+ is 0 .37511/0.19795 = 1.9
times higher in males than in females, and that the lethality in the 60+ group70
compared to the group with less than 20 years age is:
4
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted August 11, 2020. ; https://doi.org/10.1101/2020.06.28.20142117doi: medRxiv preprint
0.37511 + 0.19705
0.00068 + 0.00024 + 0.00041 + 0.00048= 317.7
times larger. Table 3 also shows that the lethality among people 50 years or
older is about 6 times larger than among people less than 50 years old.
3. Adjusted lethality
It is possible to estimate the true values of θM andθF . The lethality of the75
disease is the probability that a person at random that has been infected with
SARS-CoV-2 dies, which is:
IFR = f′
MθM + f′
FθF (6)
which assumes all individuals are equally likely to become infected. If we have
an estimate of the lethality of the disease, θ, then we can rescale θ∗
M and θ∗
F
multiplying by a constant c so that80
θ =c f′
Mθ∗
M +c f′
Fθ∗
F (7)
Some estimates of the IFR are in the range 0 .05%− 0.25% [5, 6, 7]. Here we
will use the lethality reported by [5] of 86 in 100, 000 (about 0.1%) because it
is a more recent study with a large sample size, thus, we use θ = 0.001. The
adjusted lethalities by age group and gender are shown in Table 4.
One immediate application of Table 4 is the possibility of projecting the85
IFR for another population whose demographics by age and gender are known.
Consider for instance the demographics of the Za’atari refugee camp, in Jordan1,
which is shown in Table 5. We use θM andθF from Table 4 and the fM and fF
from the camp’s demographic and thus the IFR projected for this camp is:
IFR = f′
MθM + f′
FθF = 0.00037
1https://data2.unhcr.org/en/situations/syria/location/53
5
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted August 11, 2020. ; https://doi.org/10.1101/2020.06.28.20142117doi: medRxiv preprint
Observe this adjusted lethality is about 2.7 times smaller than the overall90
IFR, which is due to the fact that Za’atari refugee camp is a young population
with 3/4 of the refugees being less than 30 years old. Although this comparison
used θ = 0.001 as the overall IFR of SARS-CoV-2, the observed ratio of 2.7
is independent of this value because the adjusting constant c in 7 cancels out.
Clearly, this projection includes only demographic factors and not other health95
and socioeconomic factors or availability of health services. Figure 2 shows a
comparison between the demographics of the Za’atari camp and the Adjusted
lethalities from Table 4 by age group and gender.
0.0%
0.1%
0.2%
0.3%
0.4%
0.5%
0.6%
0.7%
0.8%
0.9%
1.0%
1 2 3 4 5 6 7
Male Female
Figure
2: Population frequency in Za’atari camp (left) and Adjusted lethalities from Table 4
(right) by age and gender. For this particular camp, the lethality affects a group of individuals
that are found at a very low frequency in the camp.
The distribution of deaths across age groups and gender.
Another use of the adjusted lethalities in Table 4 is the estimation of the100
distribution of deaths across group ages and genders. The question we want to
answer is: what is the probability that a dead individual belongs to a particular
gender and age group? This is clearly given by fM◦θM and fF◦θF after
normalization. For the Mexican population, a plot of this distribution is given
in Figure 3.105
6
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted August 11, 2020. ; https://doi.org/10.1101/2020.06.28.20142117doi: medRxiv preprint
0%
5%
10%
15%
20%
25%
30%
35%
40%
1 2 3 4 5 6 7
Male Female
Figure 3: The projected distribution of deaths across age groups and gender for Mexico’s
population.
4. Bibliography
[1] F. Zhou, T. Yu, R. Du, G. Fan, Y. Liu, Z. Liu, J. Xiang, Y. Wang, B. Song,
X. Gu, et al., Clinical course and risk factors for mortality of adult inpatients
with covid-19 in wuhan, china: a retrospective cohort study, The lancet.
[2] K. Gostic, A. C. Gomez, R. O. Mummah, A. J. Kucharski, J. O. Lloyd-110
Smith, Estimated effectiveness of symptom and risk screening to prevent
the spread of covid-19, Elife 9 (2020) e55570. doi:10.7554/eLife.55570.
[3] World Health Organization, Coronavirus disease (COVID-2019) situation
reports: Situation report - 150, June 18, 2020, Accessed on June 19, 2020.
URL https://www.who.int/docs/default-source/coronaviruse/115
situation-reports/20200618-covid-19-sitrep-150.pdf?sfvrsn=
aa9fe9cf_2
[4] W. Tian, W. Jiang, J. Yao, C. J. Nicholson, R. H. Li, H. H. Sigurslid,
L. Wooster, J. I. Rotter, X. Guo, R. Malhotra, Predictors of mortality in
hospitalized covid-19 patients: A systematic review and meta-analysis, Jour-120
nal of Medical Virologydoi:10.1002/jmv.26050.
7
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted August 11, 2020. ; https://doi.org/10.1101/2020.06.28.20142117doi: medRxiv preprint
[5] C. Erikstrup, C. E. Hother, O. B. V. Pedersen, K. Mølbak, R. L. Skov,
D. K. Holm, S. Sækmose, A. C. Nilsson, P. T. Brooks, J. K. Boldsen,
C. Mikkelsen, M. Gybel-Brask, E. Sørensen, K. M. Dinh, S. Mikkelsen,
B. K. Møller, T. Haunstrup, L. Harritshøj, B. A. Jensen, H. Hjalgrim,125
S. T. Lillevang, H. Ullum, Estimation of SARS-CoV-2 infection fatal-
ity rate by real-time antibody screening of blood donors, medRxiv doi:
10.1101/2020.04.24.20075291.
[6] H. Streeck, B. Schulte, B. Kuemmerer, E. Richter, T. Hoeller, C. Fuhrmann,
E. Bartok, R. Dolscheid, M. Berger, L. Wessendorf, M. Eschbach-Bludau,130
A. Kellings, A. Schwaiger, M. Coenen, P. Hoffmann, M. Noethen, A.-M.
Eis-Huebinger, M. Exner, R. Schmithausen, M. Schmid, B. Kuemmerer,
Infection fatality rate of SARS-CoV-2 infection in a german community with
a super-spreading event, medRxivdoi:10.1101/2020.05.04.20090076.
[7] J. Ioannidis, The infection fatality rate of COVID-19 inferred from sero-135
prevalence data, medRxivdoi:10.1101/2020.05.13.20101253.
Conflicts of interest
Authors declare no conflict of interest.
Funding and study approval
This work is part of the program “Building the Evidence on Protracted140
Forced Displacement: A Multi-Stakeholder Partnership”. The program is funded
by UK aid from the United Kingdom’s Department for International Develop-
ment (DFID), it is managed by the World Bank Group (WBG) and was estab-
lished in partnership with the United Nations High Commissioner for Refugees
(UNHCR). The scope of the program is to expand the global knowledge on145
forced displacement by funding quality research and disseminating results for
the use of practitioners and policy makers. This work does not necessarily reflect
8
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted August 11, 2020. ; https://doi.org/10.1101/2020.06.28.20142117doi: medRxiv preprint
the views of DFID, the WBG or UNHCR. This study had approval R-2020-601-
07 by the Health Research Ethics Committee (601) of the IMSS.
9
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted August 11, 2020. ; https://doi.org/10.1101/2020.06.28.20142117doi: medRxiv preprint
Table 1: Number of transitions between compartments in Figure 1 by age group and gender.
Males
Age N N 0 N1 N2 N3 N4 N5 N6
0-9 256 97 159 116 20 23 14 6
10-19 367 261 106 83 6 17 3 3
20-29 5,627 4,585 1,042 852 8 182 6 2
30-39 10,829 7,706 3,123 2,289 29 805 14 15
40-49 11,788 6,153 5,635 3,539 65 2,031 32 33
50-59 11,566 3,799 7,767 3,914 65 3,788 24 41
60 + 16,392 2,599 13,793 4,407 111 9,275 27 84
Total 56,825 25,200 31,625 15,200 304 16,121 120 184
Females
Age N N 0 N1 N2 N3 N4 N5 N6
0-9 205 90 115 81 17 17 14 3
10-19 423 316 107 80 3 24 2 1
20-29 5,778 4,972 806 684 15 107 13 2
30-39 9,894 8,211 1,683 1,330 29 324 23 6
40-49 10,128 6,868 3,260 2,260 22 978 8 14
50-59 8,274 3,515 4,759 2,755 33 1,971 13 20
60 + 11,458 2,068 9,390 3,600 54 5,736 12 42
Total 46,160 26,040 20,120 10,790 173 9,157 85 88
10
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted August 11, 2020. ; https://doi.org/10.1101/2020.06.28.20142117doi: medRxiv preprint
Table 2: Statistics associated with the transition of COVID-19 patients between compartments
in Figure 1. h = distribution of patients arriving to hospitals. c = probability of requiring
ICU among those that went into hospitalization; d = probability of dying among those that
went into hospitalization; dc = probability of dying among those that went into ICU.
Males
Age h c d d c
0-9 0.0031 0.1258 0.1824 0.3000
10-19 0.0020 0.0566 0.1887 0.5000
20-29 0.0201 0.0077 0.1766 0.2500
30-39 0.0604 0.0093 0.2626 0.5172
40-49 0.1089 0.0115 0.3663 0.5077
50-59 0.1501 0.0084 0.4930 0.6308
60 + 0.2666 0.0080 0.6785 0.7568
Females
Age h c d d c
0-9 0.0022 0.1478 0.1739 0.1765
10-19 0.0021 0.0280 0.2336 0.3333
20-29 0.0156 0.0186 0.1352 0.1333
30-39 0.0325 0.0172 0.1961 0.2069
40-49 0.0630 0.0067 0.3043 0.6364
50-59 0.0920 0.0069 0.4184 0.6061
60 + 0.1815 0.0058 0.6153 0.7778
11
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted August 11, 2020. ; https://doi.org/10.1101/2020.06.28.20142117doi: medRxiv preprint
Table 3: Normalized relative lethalities. “ ◦” and “ ⊘” are the Hadamard element-by-element
multiplication and division respectively.
Males
θ∗
M
Age f M h d h ◦ d⊘ f M
0-9 0.09871 0.00307 0.18239 0.00052
10-19 0.09976 0.00205 0.18868 0.00036
20-29 0.08130 0.02014 0.17658 0.00403
30-39 0.07203 0.06035 0.26257 0.02029
40-49 0.05566 0.10890 0.36628 0.06609
50-59 0.03851 0.15010 0.49298 0.17722
60 + 0.04218 0.26656 0.67853 0.39548
Females
θ∗
F
Age f F h d h ◦ d⊘ f F
0-9 0.09577 0.0022 0.1739 0.00037
10-19 0.09824 0.0021 0.2336 0.00045
20-29 0.08709 0.0156 0.1352 0.00223
30-39 0.07908 0.0325 0.1961 0.00744
40-49 0.06096 0.0630 0.3043 0.02900
50-59 0.04225 0.0920 0.4184 0.08399
60 + 0.04846 0.1815 0.6153 0.21252
12
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted August 11, 2020. ; https://doi.org/10.1101/2020.06.28.20142117doi: medRxiv preprint
Table 4: Adjusted lethalities by age group and gender for the Mexican population( M=male,
F =female). The adjusted lethalities are obtained from rescaling the unadjusted lethalities in
Table 3, so that f′
M θM + f′
F θF = 0.001.Age θM θF
0-9 0.00001 0.00001
10-19 0.00001 0.00001
20-29 0.00009 0.00005
30-39 0.00045 0.00016
40-49 0.00145 0.00064
50-59 0.00389 0.00184
60 + 0.00868 0.00467
Table 5: Population structure of Syrian refugees in Jordan.
Age fM fF
0-9 0.1934 0.1823
10-19 0.1190 0.1116
20-29 0.0714 0.0794
30-39 0.0574 0.0611
40-49 0.0337 0.0348
50-59 0.0127 0.0171
60 + 0.0110 0.0150
Total 0.4987 0.5013
13
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted August 11, 2020. ; https://doi.org/10.1101/2020.06.28.20142117doi: medRxiv preprint